Source: https://www.nytimes.com/2020/01/27/business/martin-shkreli-ftc-lawsuit.html?emc=rss&partner=rss
January 28, 2020 at 04:02AM
A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.
No comments:
Post a Comment